Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 10/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CFTR | P13569 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14012717 | 1.00 | ESR1 (0.58) | ESR1ESR2HTTNPSR1CA2 | |
| SCHEMBL14012716 | 0.89 | ESR1 (0.42) | ESR1ESR2IDO1 | |
| SCHEMBL517954 | 0.83 | ESR1 (0.68) | ESR1ESR2HTTNPSR1CA2 | |
| SCHEMBL31176947 | 0.80 | ESR1 (0.65) | ESR1ESR2HTTNPSR1CA2 | |
| Phosphine SCHEMBL15190577 | 0.80 | ESR1 (0.65) | ESR1ESR2HTTNPSR1CA2 | |
| SCHEMBL9772833 | 0.80 | ESR1 (0.65) | ESR1ESR2HTTNPSR1CA2 | |
| SCHEMBL4780784 | 0.78 | ESR1 (0.64) | ESR1ESR2HTTNPSR1CA2 | |
| SCHEMBL10522576 | 0.74 | ESR1 (0.58) | ESR1ESR2HTTNPSR1CA2 | |
| SCHEMBL10520597 | 0.74 | ESR1 (0.58) | ESR1ESR2HTTNPSR1L3MBTL1 | |
| SCHEMBL18577902 | 0.74 | ESR1 (0.58) | ESR1ESR2HTTNPSR1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7446228-B2 | Thiophosphine compounds | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2008-11-04 | — | — | US | disclosed |
| US-7446228-B2 | Thiophosphine compounds | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2008-11-04 | — | — | US | disclosed |
| US-7378556-B2 | Process for making thiophosphine compounds | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2008-05-27 | — | — | US | disclosed |
| US-7378556-B2 | Process for making thiophosphine compounds | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2008-05-27 | — | — | US | disclosed |
| EP-1608704-B1 | THIOPHOSPHINE COMPOUNDS AND METHOD OF MAKING POLYMERISABLE COMPOSITIONS CONTAINING THEM AND THEIR USE FOR MAKING OPHTALMIC LENSES | ESSILOR INT (FR) | 2008-03-19 | — | — | EP | disclosed |
| US-20070232834-A1 | THIOPHOSPHINE COMPOUNDS AND METHODS OF MAKING POLYMERIZABLE COMPOSITIONS CONTAINING THEM AND THEIR USE FOR MAKING OPHTHALMIC LENSES | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2007-10-04 | — | — | US | disclosed |
| US-20070232834-A1 | THIOPHOSPHINE COMPOUNDS AND METHODS OF MAKING POLYMERIZABLE COMPOSITIONS CONTAINING THEM AND THEIR USE FOR MAKING OPHTHALMIC LENSES | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2007-10-04 | — | — | US | disclosed |
| US-20070232835-A1 | THIOPHOSPHINE COMPOUNDS AND METHODS OF MAKING POLYMERIZABLE COMPOSITIONS CONTAINING THEM AND THEIR USE FOR MAKING OPHTHALMIC LENSES | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2007-10-04 | — | — | US | disclosed |
| US-20070232835-A1 | THIOPHOSPHINE COMPOUNDS AND METHODS OF MAKING POLYMERIZABLE COMPOSITIONS CONTAINING THEM AND THEIR USE FOR MAKING OPHTHALMIC LENSES | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232835-A1 | THIOPHOSPHINE COMPOUNDS AND METHODS OF MAKING POLYMERIZABLE COMPOSITIONS CONTAINING THEM AND THEIR USE FOR MAKING OPHTHALMIC LENSES | PHOSPHO1, TST, UACA | ESR1 4716/4885ESR2 4648/4885HTT 1661/4885 |
| US-20070232834-A1 | THIOPHOSPHINE COMPOUNDS AND METHODS OF MAKING POLYMERIZABLE COMPOSITIONS CONTAINING THEM AND THEIR USE FOR MAKING OPHTHALMIC LENSES | PHOSPHO1, TST, UACA | ESR1 4716/4885ESR2 4648/4885HTT 1661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.